{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:39:10Z","timestamp":1786984750473,"version":"build-2736575974"},"reference-count":172,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.arr.2025.103000","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T06:00:02Z","timestamp":1766124002000},"page":"103000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Protein and peptide based nanotherapeutics for the management of Alzheimer\u2019s disease: Current insights and future directions"],"prefix":"10.1016","volume":"114","author":[{"given":"Sandeep Kumar","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaustubh Ajit","family":"Kolekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vancha","family":"Harish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepshikha","family":"Patle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukriti","family":"Vishwas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Dureja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowthamarajan","family":"Kuppusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3823-6572","authenticated-orcid":false,"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2025.103000_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/polym13071051","article-title":"Potential role of nanoparticles in treating the accumulation of amyloid-beta peptide in alzheimer\u2019s patients","volume":"13","author":"Abbas","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.arr.2025.103000_bib2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1021\/cn100057j","article-title":"Oral treatment with the d-enantiomeric peptide D3 improves the pathology and behavior of alzheimer\u2019s disease transgenic mice","volume":"1","author":"Aileen Funke","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2025.103000_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nano10081590","article-title":"A peptide-based nanocarrier for an enhanced delivery and targeting of flurbiprofen into the brain for the treatment of alzheimer\u2019s disease: an in vitro study","volume":"10","author":"Al-Azzawi","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.arr.2025.103000_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neuroscience.2025.01.040","article-title":"The possible role of cerebrolysin in the management of vascular dementia: leveraging concepts","volume":"568","author":"Al-Kuraishy","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2025.103000_bib5","first-page":"826","article-title":"Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer\u2019s disease mice","volume":"140","author":"Alves","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.arr.2025.103000_bib6","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.1021\/bi300415v","article-title":"The N-methylated peptide SEN304 powerfully inhibits A\u03b2(1-42) toxicity by perturbing oligomer formation","volume":"51","author":"Amijee","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2025.103000_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113270","article-title":"Caffeic acid loaded into engineered lipid nanoparticles for Alzheimer\u2019s disease therapy","volume":"225","author":"Andrade","year":"2023","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.arr.2025.103000_bib8","doi-asserted-by":"crossref","unstructured":"Ariawan, D., Thananthirige, K.P.M., El-omar, A., Hoven, J.Van Der, Genoud, S., Stefen, H., Fath, T., Eersel, J.Van, Ittner, L.M., Tietz, O., 2024. Design of peptide therapeutics as protein \u2013 protein interaction inhibitors to treat neurodegenerative diseases \u2020 34637\u201334642. https:\/\/doi.org\/10.1039\/d4ra05040a.","DOI":"10.1039\/D4RA05040A"},{"key":"10.1016\/j.arr.2025.103000_bib9","article-title":"Cyclic glycine-proline improves memory and reduces amyloid plaque load in APP\/PS1 transgenic mouse model of Alzheimer\u2019s Disease","volume":"2023","author":"Arora","year":"2023","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2025.103000_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17040397","article-title":"Barriers and strategies for oral peptide and protein therapeutics delivery: update on clinical advances","volume":"17","author":"Baral","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2025.103000_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102236","article-title":"Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation","author":"Bashir","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.103000_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102689","article-title":"Bridging gap in the treatment of Alzheimer\u2019s disease via postbiotics: Current practices and future prospects","volume":"105","author":"Bashir","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.103000_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102689","article-title":"Bridging gap in the treatment of Alzheimer\u2019s disease via postbiotics: Current practices and future prospects","volume":"105","author":"Bashir","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.103000_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102693","article-title":"Does drug repurposing bridge the gaps in management of Parkinson\u2019s disease? Unravelling the facts and fallacies","volume":"105","author":"Bashir","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.103000_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2025.104052","article-title":"Bridging the gap in the management of Alzheimer\u2019s disease using fecal microbiota transplantation","volume":"135","author":"Bashir","year":"2025","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.arr.2025.103000_bib16","series-title":"Heavy Metal Toxicity and Neurodegeneration","first-page":"225","article-title":"Chapter 12 - Heavy metals and Alzheimer\u2019s disease: a review","author":"Bashir","year":"2025"},{"key":"10.1016\/j.arr.2025.103000_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27248823","article-title":"BACE1 Inhibitors for Alzheimer\u2019s Disease: the past, present and any future?","author":"Bazzari","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2025.103000_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1459224","article-title":"In 2024, the amyloid-cascade-hypothesis still remains a working hypothesis, no less but certainly no more","volume":"16","author":"Behl","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2025.103000_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mito.2021.02.007","article-title":"Protective effects of a mitochondria-targeted small peptide SS31 against hyperglycemia-induced mitochondrial abnormalities in the liver tissues of diabetic mice, Tallyho\/JngJ mice","volume":"58","author":"Bhatti","year":"2021","journal-title":"Mitochondrion"},{"key":"10.1016\/j.arr.2025.103000_bib20","doi-asserted-by":"crossref","unstructured":"Bhatti, J.S., Thamarai, K., Kandimalla, R., Manczak, M., Yin, X., 2021b. Mitochondria-Targeted Small Peptide, SS31 Ameliorates Diabetes Induced Mitochondrial Dynamics in Male TallyHO \/ JngJ Mice 795\u2013808.","DOI":"10.1007\/s12035-020-02142-7"},{"key":"10.1016\/j.arr.2025.103000_bib21","first-page":"215","article-title":"Role of immunogenicity in drug development","volume":"11","author":"Bhowmick","year":"2024","journal-title":"Era\u2019S. J. Med. Res."},{"key":"10.1016\/j.arr.2025.103000_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e40563","article-title":"Bioactive peptides from food science to pharmaceutical industries: their mechanism of action, potential role in cancer treatment and available resources","volume":"10","author":"Bidram","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.arr.2025.103000_bib23","doi-asserted-by":"crossref","first-page":"10915","DOI":"10.1007\/s12035-025-04917-2","article-title":"Functionalized nanoparticles: a promising approach for effective management of Alzheimer\u2019s Disease","volume":"62","author":"Bogadi","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2025.103000_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41578-022-00458-5","article-title":"Polymeric particle-based therapies for acute inflammatory diseases","author":"Brannon","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.arr.2025.103000_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on Alzheimer\u2019s Disease: causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2025.103000_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/srep13222","article-title":"QIAD assay for quantitating a compounds efficacy in elimination of toxic A\u03b2 oligomers","volume":"5","author":"Brener","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.103000_bib27","first-page":"4515","article-title":"Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer \u2019 s disease","volume":"20","author":"Calkins","year":"2011"},{"key":"10.1016\/j.arr.2025.103000_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-00864-x","article-title":"Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer\u2019s disease: from current to future challenges","volume":"19","author":"Cano","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.arr.2025.103000_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010064","article-title":"Carnosine prevents A\u03b2-induced oxidative stress and inflammation in microglial cells: A key role of TGF-\u03b21","volume":"8","author":"Caruso","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.arr.2025.103000_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.arr.2025.103000_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2025.101583","article-title":"Advances in targeted therapy for tumor with nanocarriers: A review","author":"Cheng","year":"2025","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.arr.2025.103000_bib32","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/wics.1310","article-title":"Bioavailability and bioequivalence in drug development","volume":"6","author":"Chow","year":"2014","journal-title":"Wiley Interdiscip. Rev. Comput. Stat."},{"key":"10.1016\/j.arr.2025.103000_bib33","series-title":"Brain Pathology","first-page":"342","article-title":"Prion-Like\u201d templated misfolding in tauopathies","author":"Clavaguera","year":"2013"},{"key":"10.1016\/j.arr.2025.103000_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113761","article-title":"Familial Alzheimer mutations stabilize synaptotoxic \u03b3-secretase-substrate complexes","volume":"43","author":"Devkota","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.arr.2025.103000_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400180","article-title":"Tau protein and tauopathies: Exploring Tau Protein\u2013Protein and microtubule interactions, cross-interactions and therapeutic strategies","volume":"19","author":"Di Lorenzo","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.arr.2025.103000_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131739","article-title":"Glucose-modified BSA\/procyanidin C1 NPs penetrate the blood-brain barrier and alleviate neuroinflammation in Alzheimer\u2019s disease models","volume":"268","author":"Duan","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2025.103000_bib37","first-page":"549","article-title":"Polymeric nanoparticles: A promising strategy for treatment of Alzheimer\u2019s disease","volume":"19","author":"Elmahboub","year":"2024","journal-title":"J. Taibah Univ. Med. Sci."},{"key":"10.1016\/j.arr.2025.103000_bib38","series-title":"in: Pharmacological Mechanisms in Alzheimer\u2019s Therapeutics","first-page":"238","article-title":"Design of inhibitors of amyloid-\u03b2 misfolding and aggregation for Alzheimer\u2019s therapy","author":"Estrada","year":"2007"},{"key":"10.1016\/j.arr.2025.103000_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2015.02.041","article-title":"\u03b2-Sheet interfering molecules acting against \u03b2-amyloid aggregation and fibrillogenesis","author":"Francioso","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.arr.2025.103000_bib40","article-title":"Prioritizing repurposable drugs for Alzheimer \u2019 s disease using network-based analysis with concurrent assessment of Long QT syndrome risk","volume":"47","author":"Funari","year":"2025","journal-title":"Biotechnol. Rep."},{"key":"10.1016\/j.arr.2025.103000_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2022.937133","article-title":"Neuronal cell death mechanisms in Alzheimer\u2019s disease: An insight","volume":"15","author":"Goel","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2025.103000_bib42","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.neuropharm.2004.07.002","article-title":"Neuroprotective effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate (GPE) following intravenous infusion in hypoxic-ischemic adult rats","volume":"47","author":"Guan","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2025.103000_bib43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijbiomac.2019.02.156","article-title":"Nanoparticle formulations in the diagnosis and therapy of Alzheimer\u2019s disease","volume":"130","author":"Gupta","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2025.103000_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2025.100235","article-title":"Hyperphosphorylated tau-based Alzheimer\u2019s Disease drug discovery: identification of inhibitors of tau aggregation and cytotoxicity","volume":"33","author":"Hagar","year":"2025","journal-title":"SLAS Discov."},{"key":"10.1016\/j.arr.2025.103000_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2020.02.001","article-title":"The \u03b2-Secretase BACE1 in Alzheimer\u2019s Disease","author":"Hampel","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2025.103000_bib46","unstructured":"Han, M.G., 2025. LibGuides: Mendeley - Manage and Share your Research: Adding References. https:\/\/doi.org\/doi."},{"key":"10.1016\/j.arr.2025.103000_bib47","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.nbd.2009.03.007","article-title":"Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer\u2019s disease","volume":"34","author":"Handattu","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2025.103000_bib48","article-title":"Designed \u03b1-sheet peptides inhibit amyloid formation by targeting toxic oligomers","author":"Hopping","year":"2014","journal-title":"Elife 2014"},{"key":"10.1016\/j.arr.2025.103000_bib49","doi-asserted-by":"crossref","first-page":"81001","DOI":"10.18632\/oncotarget.20944","article-title":"PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering A\u03b2 generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer\u2019s disease mice","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.arr.2025.103000_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-022-00754-8","article-title":"\u03b3-Secretase in Alzheimer\u2019s disease","author":"Hur","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.arr.2025.103000_bib51","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1007\/s00044-012-0386-2","article-title":"Synthesis of d-amino acid peptides and their effect on beta-amyloid aggregation and toxicity in transgenic Caenorhabditis elegans","volume":"22","author":"Jagota","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.arr.2025.103000_bib52","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.14283\/jpad.2024.153","article-title":"Progress in the Treatment of Alzheimer\u2019s Disease Is Needed \u2013 Position Statement of European Alzheimer\u2019s Disease Consortium (EADC) Investigators","volume":"11","author":"Jessen","year":"2024","journal-title":"J. Prev. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2025.103000_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/ange.202308251","article-title":"Cyclic peptides for drug development","volume":"136","author":"Ji","year":"2024","journal-title":"Angew. Chem."},{"key":"10.1016\/j.arr.2025.103000_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115114","article-title":"Protein corona on brain targeted nanocarriers: Challenges and prospects","author":"Jiang","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2025.103000_bib55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.36255\/exonpublications.alzheimersdisease.2020.ch3","article-title":"Amyloid \u00df-targeted inhibitory peptides for Alzheimer\u2019s Disease: current state and future perspectives","author":"Jokar","year":"2020","journal-title":"Alzheimer\u2019S. Dis. Drug Discov."},{"key":"10.1016\/j.arr.2025.103000_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/nano13030574","article-title":"Nanoparticles: taking a unique position in medicine","author":"Joseph","year":"2023","journal-title":"Nanomaterials"},{"key":"10.1016\/j.arr.2025.103000_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11112167","article-title":"The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer\u2019s Disease: therapeutic implications and future perspectives","volume":"11","author":"Jurc\u0103u","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.arr.2025.103000_bib58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1074-5521(03)00022-X","article-title":"Conformational restriction via cyclization in \u03b2-amyloid peptide A\u03b2(1-28) leads to an inhibitor of A\u03b2(1-28) amyloidogenesis and cytotoxicity","volume":"10","author":"Kapurniotu","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.arr.2025.103000_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8147080","article-title":"Nanoparticle therapy is a promising approach in the management and prevention of many diseases: does it help in curing Alzheimer disease?","volume":"2020","author":"Kassem","year":"2020","journal-title":"J. Nanotechnol."},{"key":"10.1016\/j.arr.2025.103000_bib60","first-page":"1","article-title":"Unravelling role of crocin for the treatment of Alzheimer\u2019s and Parkinson\u2019s disease: sojourn from food to nanomedicine","author":"Kaur","year":"2024","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.arr.2025.103000_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9704","article-title":"The BACE1 inhibitor verubecestat (MK-8931) reduces CNS b-Amyloid in animal models and in Alzheimer\u2019s disease patients","volume":"8","author":"Kennedy","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2025.103000_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2009.01.022","article-title":"Prevent Alzheimer\u2019s disease by 2020: A national strategic goal","author":"Khachaturian","year":"2009","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.arr.2025.103000_bib63","article-title":"Quality by design endorsed fabrication of xanthohumol loaded solid nanostructured lipid carrier based powder for effective treatment of Alzheimer\u2019s disease in rats","volume":"107","author":"Khandale","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.arr.2025.103000_bib64","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1016\/j.bmcl.2015.05.027","article-title":"Covalent modifier-type aggregation inhibitor of amyloid-\u03b2 based on a cyclo-KLVFF motif","volume":"25","author":"Kino","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.arr.2025.103000_bib65","article-title":"Nose to brain delivery of insulin loaded in PLGA and chitosan-coated PLGA nanoparticles: A promising approach for Alzheimer\u2019s disease therapy","volume":"108","author":"Kouhjani","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.arr.2025.103000_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105973","article-title":"Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease","volume":"174","author":"Kshirsagar","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.arr.2025.103000_bib67","first-page":"1","article-title":"Challenges in biomaterial-based drug delivery approach for the treatment of neurodegenerative diseases: Opportunities for extracellular vesicles","volume":"22","author":"Kumar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.103000_bib68","doi-asserted-by":"crossref","DOI":"10.4161\/pri.28220","article-title":"D-amino acid-based peptide inhibitors as early or preventative therapy in Alzheimer disease","author":"Kumar","year":"2014","journal-title":"Prion"},{"key":"10.1016\/j.arr.2025.103000_bib69","series-title":"Drug Delivery and Translational Research","article-title":"Plant-based flavonoids and their nanoparticles: Latest arsenal against Alzheimer\u2019s disease","author":"Kumbhar","year":"2025"},{"key":"10.1016\/j.arr.2025.103000_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/biom13030453","article-title":"The Amyloid Cascade Hypothesis in Alzheimer\u2019s Disease: Should We Change Our Thinking?","author":"Kurkinen","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2025.103000_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22101693","article-title":"Large-scale oral treatment study with the four most promising D3-derivatives for the treatment of Alzheimer\u2019s disease","volume":"22","author":"Kutzsche","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2025.103000_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.939855","article-title":"Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer\u2019s disease: current trends and future perspectives","author":"La Barbera","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2025.103000_bib73","doi-asserted-by":"crossref","DOI":"10.4155\/fdd-2022-0005","article-title":"Overcoming the shortcomings of peptide-based therapeutics","volume":"4","author":"Lamers","year":"2022","journal-title":"Futur. Drug Discov."},{"key":"10.1016\/j.arr.2025.103000_bib74","doi-asserted-by":"crossref","unstructured":"Lee, H., Kumar, P., Fu, Q., Rosen, K.M., Querfurth, H.W., 2009. The Insulin \/ Akt Signaling Pathway Is Targeted by Intracellular \u2424 -Amyloid 20, 1533\u20131544. https:\/\/doi.org\/10.1091\/mbc.E08.","DOI":"10.1091\/mbc.e08-07-0777"},{"key":"10.1016\/j.arr.2025.103000_bib75","doi-asserted-by":"crossref","DOI":"10.1007\/s00894-016-2960-x","article-title":"Investigation of the effect of erythrosine B on amyloid beta peptide using molecular modeling","volume":"22","author":"Lee","year":"2016","journal-title":"J. Mol. Model"},{"key":"10.1016\/j.arr.2025.103000_bib76","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejps.2016.04.016","article-title":"Pharmacokinetic properties of tandem d-peptides designed for treatment of Alzheimer\u2019s disease","volume":"89","author":"Leithold","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.arr.2025.103000_bib77","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1021\/acschemneuro.6b00154","article-title":"Modulation of Amyloid \u03b2-Protein (A\u03b2) Assembly by Homologous C-Terminal Fragments as a Strategy for Inhibiting A\u03b2 Toxicity","volume":"7","author":"Li","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2025.103000_bib78","article-title":"Unnatural foldamers as inhibitors of A\u03b2 aggregation via stabilizing the A\u03b2 helix","author":"Liu","year":"2025","journal-title":"Chem. Commun."},{"key":"10.1016\/j.arr.2025.103000_bib79","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/bm401795e","article-title":"Study on the efficiency and interaction mechanism of a decapeptide inhibitor of \u03b2-amyloid aggregation","volume":"15","author":"Liu","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.arr.2025.103000_bib80","article-title":"Three-dimensional interactive network: Mitochondrial-metabolic-calcium homeostasis driving Alzheimer\u2019s disease","author":"Liu","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/j.arr.2025.103000_bib81","article-title":"Secretases related to amyloid precursor protein processing","author":"Liu","year":"2021","journal-title":"Membr. (Basel)"},{"key":"10.1016\/j.arr.2025.103000_bib82","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1021\/acs.biochem.9b00696","article-title":"Insulin Inhibits A\u03b242 Aggregation and Prevents A\u03b242-Induced Membrane Disruption","volume":"58","author":"Long","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2025.103000_bib83","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1039\/C3TB21483D","article-title":"Fluorinated beta-sheet breaker peptides","volume":"2","author":"Loureiro","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.arr.2025.103000_bib84","doi-asserted-by":"crossref","unstructured":"Loureiro, J.A., Ramalho, M.J., Pereira, C., 2020. Immuno-Nanocarriers for Brain Delivery: Limitations From In Vitro to Preclinical and Clinical Studies Immuno-nanocarriers for brain delivery: limitations from in vitro to preclinical and clinical studies 5889, 5\u20138. https:\/\/doi.org\/10.2217\/nnm-2019-0402.","DOI":"10.2217\/nnm-2019-0402"},{"key":"10.1016\/j.arr.2025.103000_bib85","doi-asserted-by":"crossref","DOI":"10.4155\/fso.15.9","article-title":"The role and therapeutic targeting of \u03b1-, \u03b2-and \u03b3-secretase in Alzheimer\u2019s disease","author":"Macleod","year":"2015","journal-title":"Futur. Sci. OA 1"},{"key":"10.1016\/j.arr.2025.103000_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.143300","article-title":"Intranasal resveratrol delivery to the brain with chitosan-decorated bovine serum albumin nanoparticles: Advancing Alzheimer\u2019s management in old female rats through QbD-based optimization, in vitro evaluation, and in vivo exploration","volume":"311","author":"Malaiya","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2025.103000_bib87","doi-asserted-by":"crossref","DOI":"10.1021\/acs.chemrev.9b00472","article-title":"Peptide-Based Vaccines: Current Progress and Future Challenges","author":"Malonis","year":"2020","journal-title":"Chem. Rev."},{"key":"10.1016\/j.arr.2025.103000_bib88","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1093\/hmg\/dds072","article-title":"Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer\u2019s disease neurons: implications for mitochondrial dysfunction and neuronal damage","volume":"21","author":"Manczak","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.arr.2025.103000_bib89","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1093\/hmg\/dds360","article-title":"Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"21","author":"Manczak","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.arr.2025.103000_bib90","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1385\/JMN\/31:02:165","article-title":"Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer\u2019s disease at early pathological stage","volume":"31","author":"Matsuoka","year":"2007","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.arr.2025.103000_bib91","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-5949.2010.00177.x","article-title":"The Role of Tau in Alzheimer\u2019s Disease and Related Disorders","author":"Medeiros","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.arr.2025.103000_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125055","article-title":"Peptide-based inhibitors and nanoparticles: Emerging therapeutics for Alzheimer\u2019s disease","author":"Mojarad-Jabali","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.arr.2025.103000_bib93","doi-asserted-by":"crossref","unstructured":"Moloney, C.M., Lowe, V.J., Murray, M.E., 2021. Visualization of neurofibrillary tangle maturity in Alzheimer \u2019 s disease: A clinicopathologic perspective for biomarker research 1554\u20131574. https:\/\/doi.org\/10.1002\/alz.12321.","DOI":"10.1002\/alz.12321"},{"key":"10.1016\/j.arr.2025.103000_bib94","doi-asserted-by":"crossref","unstructured":"Moss, D.E., 2020. Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer \u2019 s Disease: Are Irreversible Inhibitors the Future\u00a0?","DOI":"10.3390\/ijms21103438"},{"key":"10.1016\/j.arr.2025.103000_bib95","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/10738584211016409","article-title":"Alzheimer\u2019s Disease: Innovative Therapeutic Approaches Based on Peptides and Nanoparticles","volume":"29","author":"Mota","year":"2023","journal-title":"Neuroscientist"},{"key":"10.1016\/j.arr.2025.103000_bib96","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ijbiomac.2022.01.117","article-title":"Amyloid \u03b2 interaction with model cell membranes \u2013 What are the toxicity-defining properties of amyloid \u03b2?","volume":"200","author":"Mrdenovic","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2025.103000_bib97","article-title":"Alzheimer\u2019s Disease Puzzle: Delving into Pathogenesis Hypotheses","author":"Nasb","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.arr.2025.103000_bib98","doi-asserted-by":"crossref","DOI":"10.1186\/s40659-022-00404-3","article-title":"Inflammation context in Alzheimer\u2019s disease, a relationship intricate to define","author":"Novoa","year":"2022","journal-title":"Biol. Res."},{"key":"10.1016\/j.arr.2025.103000_bib99","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1017\/S1461145713000886","article-title":"Novel 5-aryloxypyrimidine SEN1576 as a candidate for the treatment of Alzheimer\u2019s disease","volume":"17","author":"O\u2019Hare","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.arr.2025.103000_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125888","article-title":"Novel enabling strategies for oral peptide delivery","volume":"681","author":"\u00d6ngoren","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.arr.2025.103000_bib101","doi-asserted-by":"crossref","unstructured":"Pal, B., Panda, S., Bashir, B., Vishwas, S., Chaitanya, M., Hussain, S., 2026. Nanomedicine-enabled neuroprotection: therapeutic role of berberine in neurodegenerative diseases 1\u201324.","DOI":"10.1007\/s11033-025-11193-9"},{"key":"10.1016\/j.arr.2025.103000_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics14061117","article-title":"Therapeutic Approach to Alzheimer\u2019s Disease: Current Treatments and New Perspectives","volume":"14","author":"Pardo-Moreno","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2025.103000_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/57e0a947-8600-4658-b04c-cf7a45c8bd8d","article-title":"A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe\/PS1\u0394E9 Mouse Model of Alzheimer\u2019s Disease","volume":"8","author":"Parthsarathy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2025.103000_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213954","article-title":"Alzheimer\u2019s Disease: Treatment Strategies and Their Limitations","volume":"23","author":"Passeri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.103000_bib105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.37881\/1.832","article-title":"Limitations of Alzheimer\u2019s Disease Medications","author":"Pathan","year":"2023","journal-title":"NeuroPharmac J."},{"key":"10.1016\/j.arr.2025.103000_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.124856","article-title":"Covalent vs. Non covalent chemical modification of multiwalled carbon nanotubes based-nanofluids: Stability and thermal conductivity steadiness over temperature","volume":"404","author":"Pav\u00eda","year":"2024","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.arr.2025.103000_bib107","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.5c00044","article-title":"Investigating the Interactions of a Cyclic Peptide Hormone Somatostatin and Its Derivatives on Amyloid-Beta Aggregation","author":"Pham","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2025.103000_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/biom12101344","article-title":"From Small Peptides to Large Proteins against Alzheimer\u2019sDisease","volume":"12","author":"Picone","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2025.103000_bib109","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-020-02865-1","article-title":"RVG29-Functionalized Lipid Nanoparticles for Quercetin Brain Delivery and Alzheimer\u2019s Disease","volume":"37","author":"Pinheiro","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.arr.2025.103000_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105314","article-title":"Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer\u2019s disease","volume":"148","author":"Pinheiro","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.arr.2025.103000_bib111","series-title":"in: Alzheimer\u2019s Disease: Drug Discovery","first-page":"69","article-title":"Tau protein-targeted therapies in Alzheimer\u2019s disease: Current state and future perspectives","author":"Pluta","year":"2020"},{"key":"10.1016\/j.arr.2025.103000_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.04.014","article-title":"Improvements of symptoms of Alzheimer\u2018s disease by inhibition of the angiotensin system","author":"Quitterer","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.arr.2025.103000_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124800","article-title":"Nanosystems for targeted drug Delivery: Innovations and challenges in overcoming the Blood-Brain barrier for neurodegenerative disease and cancer therapy","author":"Rafati","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.arr.2025.103000_bib114","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3233\/JAD-160612","article-title":"Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons","volume":"57","author":"Rajmohan","year":"2017","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2025.103000_bib115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-150040","article-title":"Intranasal Delivery of NEMO-Binding Domain Peptide Prevents Memory Loss in a Mouse Model of Alzheimer\u2019s Disease","volume":"47","author":"Rangasamy","year":"2015","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2025.103000_bib116","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1096\/fj.10-180133","article-title":"Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer\u2019s disease-like pathology in amyloid precursor protein-transgenic mice","volume":"25","author":"Rat","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2025.103000_bib117","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9982954","article-title":"Inflammation and Alzheimer\u2019s Disease: Mechanisms and Therapeutic Implications by Natural Products","volume":"2021","author":"Rather","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.arr.2025.103000_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated Tau in Alzheimer\u2019s Disease and Other Tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.103000_bib119","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainresrev.2010.11.004","article-title":"Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases","volume":"67","author":"Reddy","year":"2010","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.arr.2025.103000_bib120","first-page":"1483","article-title":"Mitochondria-targeted small molecule SS31","volume":"26","author":"Reddy","year":"2017","journal-title":"a Potential Candidate Treat. Alzheimer \u2019 S. Dis."},{"key":"10.1016\/j.arr.2025.103000_bib121","unstructured":"Report, E.S., 2024. Alzheimer \u2019 s disease 1\u201341."},{"key":"10.1016\/j.arr.2025.103000_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules23020283","article-title":"Peptides as potential therapeutics for Alzheimer\u2019s disease","volume":"23","author":"Ribari\u010d","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2025.103000_bib123","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/ja310064v","article-title":"In vitro and mechanistic studies of an antiamyloidogenic self-assembled cyclic D,L-\u03b1-peptide architecture","volume":"135","author":"Richman","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.arr.2025.103000_bib124","first-page":"142","article-title":"Donanemab in early Alzheimer\u2019s Disease","volume":"22","author":"Riederer","year":"2021","journal-title":"J. fur Neurol. Neurochir. und Psychiatr."},{"key":"10.1016\/j.arr.2025.103000_bib125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.scr.2015.04.008","article-title":"Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease","volume":"15","author":"Rockenstein","year":"2015","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.arr.2025.103000_bib126","article-title":"Amyloid-beta peptide and tau protein crosstalk in Alzheimer\u2019s disease","author":"Roda","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2025.103000_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28207165","article-title":"Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era","author":"Rossino","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2025.103000_bib128","doi-asserted-by":"crossref","DOI":"10.4103\/0022-3859.188553","article-title":"Can angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer\u2019s disease? An overview of research evidence in the elderly patient population","author":"Rygiel","year":"2016","journal-title":"J. Postgrad. Med."},{"key":"10.1016\/j.arr.2025.103000_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124218","article-title":"Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer\u2019s disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis","volume":"658","author":"Saleh","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.arr.2025.103000_bib130","first-page":"1","article-title":"Advancing combination therapy for Alzheimer\u2019s disease","volume":"6","author":"Salloway","year":"2020","journal-title":"Alzheimer\u2019S. Dement. Transl. Res. Clin. Inter."},{"key":"10.1016\/j.arr.2025.103000_bib131","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168553","article-title":"Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenues","author":"Samudra","year":"2023","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.arr.2025.103000_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122759","article-title":"Access to the CNS: Strategies to overcome the BBB","author":"S\u00e1nchez-Dengra","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.arr.2025.103000_bib133","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/alz.12518","article-title":"Differential expression of tau species and the association with cognitive decline and synaptic loss in Alzheimer\u2019s disease","volume":"18","author":"Saroja","year":"2022","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.arr.2025.103000_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2025.102869","article-title":"In vitro and in silico anti-Alzheimer study of rutin embedded with zinc chloride loaded bovine serum albumin nanoparticles","volume":"95","author":"Satpathy","year":"2025","journal-title":"Tissue Cell"},{"key":"10.1016\/j.arr.2025.103000_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a006387","article-title":"Treatment strategies targeting amyloid \u03b2-protein","volume":"2","author":"Schenk","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.arr.2025.103000_bib136","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s13668-025-00669-6","article-title":"Role of Galangin for the Treatment of Alzheimer\u2019s Disease: Journey So Far and Road Ahead","volume":"14","author":"Sharma","year":"2025","journal-title":"Curr. Nutr. Rep."},{"key":"10.1016\/j.arr.2025.103000_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102876","article-title":"Quantum Dots in Neurotheranostics for the Treatment of Alzheimer\u2019s Disease","author":"Sharma","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.103000_bib138","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2011-1802","article-title":"Effect of intranasal insulin on cognitive function: A systematic review","author":"Shemesh","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.arr.2025.103000_bib139","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1096\/fj.12-217497","article-title":"A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer\u2019s disease phenotypes in model mice","volume":"27","author":"Shukla","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2025.103000_bib140","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1021\/acschemneuro.2c00675","article-title":"Concise Overview of Glypromate Neuropeptide Research: From Chemistry to Pharmacological Applications in Neurosciences","volume":"14","author":"Silva-Reis","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2025.103000_bib141","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.bbadis.2016.11.010","article-title":"Biochimica et Biophysica Acta Mitochondrial dysfunction and oxidative stress in metabolic disorders \u2014 A step towards mitochondria based therapeutic strategies \u2729","volume":"1863","author":"Singh","year":"2017","journal-title":"BBA Mol. Basis Dis."},{"key":"10.1016\/j.arr.2025.103000_bib142","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mito.2021.02.007","article-title":"Mitochondrion Protective effects of a mitochondria-targeted small peptide SS31 against hyperglycemia-induced mitochondrial abnormalities in the liver tissues of diabetic mice, Tallyho \/ JngJ mice","volume":"58","author":"Singh","year":"2021","journal-title":"Mitochondrion"},{"key":"10.1016\/j.arr.2025.103000_bib143","article-title":"BBA - Molecular Basis of Disease Targeting dynamin-related protein-1 as a potential therapeutic approach for mitochondrial dysfunction in Alzheimer \u2019 s disease","volume":"1869","author":"Singh","year":"2023","journal-title":"BBA Mol. Basis Dis."},{"key":"10.1016\/j.arr.2025.103000_bib144","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/cbic.201600243","article-title":"Ac-LPFFD-Th: A Trehalose-Conjugated Peptidomimetic as a Strong Suppressor of Amyloid-\u03b2 Oligomer Formation and Cytotoxicity","author":"Sinopoli","year":"2016","journal-title":"ChemBioChem"},{"key":"10.1016\/j.arr.2025.103000_bib145","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jconrel.2024.12.060","article-title":"Modulation of \u03b2 secretase and neuroinflammation by biomimetic nanodelivery system for Alzheimer\u2019s disease therapy","volume":"378","author":"Song","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.arr.2025.103000_bib146","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/jpet.120.265876","article-title":"High-density lipoprotein mimetic peptide 4F efficiently crosses the blood-brain barrier and modulates amyloid-\u03b2 distribution between brain and plasma","volume":"375","author":"Swaminathan","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.arr.2025.103000_bib147","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23115938","article-title":"An overview of oxidative stress, neuroinflammation and neurodegenerative diseases","author":"Teleanu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.103000_bib148","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9111278","article-title":"Peptide-based vaccines for neurodegenerative diseases: recent endeavors and future perspectives","volume":"9","author":"Vassilakopoulou","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.arr.2025.103000_bib149","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2147\/CIA.S325026","article-title":"Role of Aducanumab in the Treatment of Alzheimer\u2019s Disease: Challenges and Opportunities","volume":"17","author":"Vaz","year":"2022","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.arr.2025.103000_bib150","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2174\/0115680266296001240327090111","article-title":"Neuroprotective role of phytoconstituents-based nanoemulsion for the treatment of Alzheimer\u2019s Disease","volume":"24","author":"Vishwas","year":"2024","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.arr.2025.103000_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.106269","article-title":"Formulation and optimization of fisetin nanoemulsion for the treatment of Alzheimer\u2019s disease in rats: Pharmacokinetic and Pharmacodynamic assessment","author":"Vishwas","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.arr.2025.103000_bib152","series-title":"Multi-Factorial Approach as a Therapeutic Strategy for the Management of Alzheimer\u2019s Disease","first-page":"397","article-title":"Natural Medicines (Phytoconstituents) and Probiotics as the Future of Alzheimer\u2019s Disease","author":"Vishwas","year":"2024"},{"key":"10.1016\/j.arr.2025.103000_bib153","article-title":"Advances in Alzheimer\u2019s disease-associated A\u03b2 therapy based on peptide","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.103000_bib154","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1021\/acsabm.5c00267","article-title":"Dual-targeting protein-based delivery system for enhanced drug therapy of neurodegenerative disorders","volume":"8","author":"Wang","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.arr.2025.103000_bib155","article-title":"Nanocarrier-based targeted drug delivery for Alzheimer\u2019s disease: addressing neuroinflammation and enhancing clinical translation","author":"Wang","year":"2025","journal-title":"Front. Pharm."},{"key":"10.1016\/j.arr.2025.103000_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26020388","article-title":"Probing mechanisms and therapeutic potential of \u03b3-secretase in alzheimer\u2019s disease","author":"Wolfe","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2025.103000_bib157","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jconrel.2022.02.011","article-title":"Challenges in delivering therapeutic peptides and proteins: A silk-based solution","volume":"345","author":"Wu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.arr.2025.103000_bib158","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jconrel.2022.02.011","article-title":"Challenges in delivering therapeutic peptides and proteins: A silk-based solution","volume":"345","author":"Wu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.arr.2025.103000_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1139418","article-title":"The interaction of peptide inhibitors and A\u03b2 protein: Binding mode analysis, inhibition of the formation of A\u03b2 aggregates, and then exert neuroprotective effects","volume":"15","author":"Wu","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2025.103000_bib160","doi-asserted-by":"crossref","first-page":"42633","DOI":"10.1002\/alz.042633","article-title":"Syk inhibitor reduces oligomeric tau associated with GSK3\u03b2 inactivation and autophagy activation","volume":"16","author":"Yamaguchi","year":"2020","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.arr.2025.103000_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106656","article-title":"Syk inhibitors reduce tau protein phosphorylation and oligomerization","volume":"201","author":"Yamaguchi","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2025.103000_bib162","doi-asserted-by":"crossref","first-page":"11329","DOI":"10.1021\/bi901325g","article-title":"A peptide hairpin inhibitor of amyloid \u03b2-protein oligomerization and fibrillogenesis","volume":"48","author":"Yamin","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2025.103000_bib163","doi-asserted-by":"crossref","unstructured":"Yiannopoulou, K.G., 2020. Current and Future Treatments in Alzheimer Disease: An Update. https:\/\/doi.org\/10.1177\/1179573520907397.","DOI":"10.1177\/1179573520907397"},{"key":"10.1016\/j.arr.2025.103000_bib164","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and Future Treatments in Alzheimer Disease: An Update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.arr.2025.103000_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114778","article-title":"Peptide-loaded chitosan nanoparticles improve mitochondrial and cognitive functions via inhibition of A\u03b2-ABAD interaction in Alzheimer\u2019s disease","volume":"214","author":"Youssef","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.arr.2025.103000_bib166","first-page":"899","article-title":"Nanoparticles in relation to peptide and protein aggregation","author":"Zaman","year":"2014","journal-title":"Int. J. Nanomed. 9"},{"key":"10.1016\/j.arr.2025.103000_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35562","article-title":"Navigating the neurological frontier: Macromolecular marvels in overcoming blood-brain barrier challenges for advanced drug delivery","author":"Zeynalzadeh","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.arr.2025.103000_bib168","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Review interaction between a\u03b2 and tau in the pathogenesis of alzheimer\u2019s disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.arr.2025.103000_bib169","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1002\/1873-3468.12871","article-title":"A mimotope of A\u03b2 oligomers may also behave as a \u03b2-sheet inhibitor","volume":"591","author":"Zhang","year":"2017","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2025.103000_bib170","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14818","article-title":"GSK3: A potential target and pending issues for treatment of Alzheimer\u2019s disease","author":"Zhao","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.arr.2025.103000_bib171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/btm2.10395","article-title":"Targeted brain delivery of RVG29-modified rifampicin-loaded nanoparticles for Alzheimer\u2019s disease treatment and diagnosis","volume":"7","author":"Zhou","year":"2022","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.arr.2025.103000_bib172","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.apsb.2021.04.001","article-title":"Oral delivery of proteins and peptides: challenges, status quo and future perspectives","volume":"11","author":"Zhu","year":"2021","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725003460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725003460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:34:29Z","timestamp":1767846869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163725003460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":172,"alternative-id":["S1568163725003460"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2025.103000","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein and peptide based nanotherapeutics for the management of Alzheimer\u2019s disease: Current insights and future directions","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2025.103000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103000"}}